NLRP3 and autism: Autism behavior and proinflammatory mediator increases were also not observed in MIA offspring after the administration of a selective NLRP3 inhibitor, which closes the active enzyme conformation to the inactive state, confirming, once again, that the P2X7-NLRP3 pathway is necessary for the expression of the autistic phenotype [67].